Hadasit Bio Stock Cash Per Share
| HDST Stock | 53.10 0.00 0.00% |
Hadasit Bio fundamentals help investors to digest information that contributes to Hadasit Bio's financial success or failures. It also enables traders to predict the movement of Hadasit Stock. The fundamental analysis module provides a way to measure Hadasit Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hadasit Bio stock.
Hadasit |
Hadasit Bio Company Cash Per Share Analysis
Hadasit Bio's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Hadasit Bio Cash Per Share | 1.64 X |
Most of Hadasit Bio's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hadasit Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Hadasit Bio has a Cash Per Share of 1.64 times. This is 62.3% lower than that of the Biotechnology sector and 62.12% lower than that of the Health Care industry. The cash per share for all Israel stocks is 67.27% higher than that of the company.
Hadasit Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hadasit Bio's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Hadasit Bio could also be used in its relative valuation, which is a method of valuing Hadasit Bio by comparing valuation metrics of similar companies.Hadasit Bio is currently under evaluation in cash per share category among related companies.
Hadasit Fundamentals
| Return On Equity | -0.44 | |||
| Return On Asset | -0.0296 | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | (3.4 M) | |||
| Shares Outstanding | 11.09 M | |||
| Shares Owned By Insiders | 74.99 % | |||
| Price To Book | 0.52 X | |||
| Price To Sales | 0.90 X | |||
| Gross Profit | 35.09 M | |||
| EBITDA | 28.67 M | |||
| Net Income | 28.36 M | |||
| Cash And Equivalents | 18.14 M | |||
| Cash Per Share | 1.64 X | |||
| Debt To Equity | 0.40 % | |||
| Current Ratio | 17.76 X | |||
| Book Value Per Share | 3.59 X | |||
| Cash Flow From Operations | (2.1 M) | |||
| Earnings Per Share | 2.46 X | |||
| Beta | 0.58 | |||
| Market Capitalization | 16.9 M | |||
| Total Asset | 66.41 M | |||
| Retained Earnings | (125 M) | |||
| Working Capital | 59 M | |||
| Current Asset | 61 M | |||
| Current Liabilities | 2 M | |||
| Z Score | -1.4 | |||
| Annual Yield | 0.18 % | |||
| Net Asset | 66.41 M |
About Hadasit Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hadasit Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hadasit Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hadasit Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hadasit Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Complementary Tools for Hadasit Stock analysis
When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |